Research Tracker›Biomarker Atlas›ME/CFS›6-minute walk distance

6-minute walk distance in ME/CFS

6-minute walk distance, also described as Functional capacity, is a functional marker reported as reduced in ME/CFS (ME/CFS, CFS) when patients are compared with healthy controls. Symptom domains tied to this marker in the source include activity limitation. The evidence summarised here comes from Maksoud et al. 2023 and reflects averages across cohorts rather than any single patient's result.

↓ ReducedFunctional

Summary

Direction in ME/CFS↓ Reduced — lower than in the comparison group
CategoryFunctional
Also described asFunctional capacity
Compared againstHC (healthy controls)
Associated symptomsActivity limitation
Test typeClinical or physiological test
SourceMaksoud et al. 2023 — doi:10.1186/s12916-023-02893-9
Condition atlasME/CFS Biomarker Atlas

Other conditions where 6-minute walk distance is reported

Atlas entryDirectionCompared against
6-minute walk distance in Gulf War Illness↓ reducedvs HGV
6-minute walk distance in PACVS↓ reducedvs HC

See the cross-condition hub: 6-minute walk distance across conditions.

Trials, interventions and tests

In clinical-trial registrations this marker maps to the outcome term Functional Capacity (25 registered trials use a matching outcome measure).

Clinical trials using 6-minute walk distance as an outcome

NCT06928272Recruiting
Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study
Outcome measure: General participant reported severity of post-exertional malaise (PEM) using the FUNCAP27 questionnaire
NCT07021794Recruiting
SARS-CoV-2 Specific Monoclonal Antibody for Post-COVID-19 Conditions (Long COVID)
Outcome measure: Change in Heart Rate Post-6MWT
NCT06928116Recruiting
Heat thErapy And mobiLity in COVID-19 Survivors
Outcome measure: Short Physical Performance Battery Test
NCT07726082Recruiting
Micro-choice-based Intervention for Multicausal Fatigue
Outcome measure: Functional capacity
NCT07745699Completed
Fully Remote, Telehealth-based Ketogenic Metabolic Therapy for Long COVID
Outcome measure: Duke Activity Status Index
NCT06086379Enrolling By Invitation
Cognitive Rehabilitation Therapy for COVID-19
Outcome measure: Change in functional capacity performance z score
NCT06766825Active Not Recruiting
Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults With Post-COVID-19 Condition (PCC)
Outcome measure: To compare functional capacity changes in patients from each group using the post-COVID-19 Functional State (PCFS) scale.
NCT07317401Not Yet Recruiting
Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) to Improve Fatigue, Pain, and Quality of Life by Targeting Mitochondrial Dysfunction and Autonomic Nervous System Impairment
Outcome measure: Change in functional capacity (FUNCAP-27)

17 more trials reference this marker.

Interventions studied alongside this marker

Hypothesis-generating links from trial outcome usage and literature co-occurrence. Not treatment recommendations.

Related Functional markers in ME/CFS

Full list: ME/CFS Biomarker Atlas.

Frequently asked questions

Is 6-minute walk distance high or low in ME/CFS?

Reduced. Studies summarised in the OSMF atlas report lower 6-minute walk distance in ME/CFS than in healthy controls. Source: Maksoud et al. 2023.

What symptoms is 6-minute walk distance associated with in ME/CFS?

The cited literature associates this marker with Activity limitation. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures 6-minute walk distance?

It is measured as a clinical or physiological test. Many of the cited studies used research-grade assays, so clinical availability may vary.

Is one abnormal 6-minute walk distance result diagnostic of ME/CFS?

No. No single biomarker is diagnostic of ME/CFS. 6-minute walk distance findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is 6-minute walk distance specific to ME/CFS?

No. The same marker is also reported in Gulf War Illness, PACVS in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). 6-minute walk distance in ME/CFS: direction, evidence and what it means. OSMF Research Tracker. Retrieved November 21, 2026, from https://research.opensourcemed.info/biomarkers/me-cfs/6-minute-walk-distance.html

Last reviewed: 2026-06-29 · Page generated from me-cfs.json · Browse: ME/CFS atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.